Search

everythinglearnresearchcommunity

for

Search:↓

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

The document suggests that there might be an autoimmune link between polycystic ovary syndrome and Graves' disease.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

5α-reductase inhibitors can interfere with doping tests by masking banned substances.

Taking Saw palmetto and Pygeum africana can change the levels of certain steroids in urine, which could cause confusion in doping tests.

Many children and teens referred to gender services receive hormone treatments, but more research is needed on their long-term care and outcomes.

Homeopathic treatment improved symptoms and thyroid levels in a woman with subclinical hypothyroidism.

A 19-year-old male with delayed puberty was successfully treated for a condition that prevents normal hormone production.

Gene mutations can cause problems in male genital development.

Thyroid disease can cause hair loss and treating thyroid problems might help with hair disorders.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Eating healthy, exercising, and taking certain supplements can help manage Polycystic Ovary Syndrome symptoms.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

The guide recommends specific methods for diagnosing PCOS and various treatments for its symptoms, while considering the health impacts on adolescents.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Both genes and environmental factors like chemicals may contribute to the increase in hypospadias, but the exact causes are still unclear.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Antiandrogens can help treat skin conditions like acne and excessive hair in women when used carefully.

For women with moderate to severe unwanted hair growth or acne, birth control pills are the first choice, with other medications like cyproterone, spironolactone, flutamide, or finasteride as alternatives, and permanent hair removal should be done with electrolysis or laser.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

The document concludes that more research is needed to fully understand the causes of PCOS.

Korean patients with PCOS often have skin problems like acne and excess hair, with different symptoms based on their specific PCOS type.

Certain genetic variations in OCT1 may improve insulin sensitivity with metformin in women with PCOS.